New Search

Refine your search within these categories:

1. Human Genes: all > Basic helix-loop-helix [HGNC:BHLH] > hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [HGNC:HIF1A]

2. Interaction: Human Genes and Chemicals (group results)

3. Bioactivity

4. Semantic Terms (group results)

A. Anatomy (group results)

B. Organisms

C01. Bacterial Infections and Mycoses (group results)

C02. Virus Diseases (group results)

C03. Parasitic Diseases (group results)

C04. Neoplasms (group results)

C05. Musculoskeletal Diseases (group results)

C06. Digestive System Diseases (group results)

C07. Stomatognathic Diseases (group results)

C08. Respiratory Tract Diseases (group results)

C09. Otorhinolaryngologic Diseases (group results)

C10. Nervous System Diseases (group results)

C11. Eye Diseases (group results)

C12. Male Urogenital Diseases (group results)

C13. Female Urogenital Diseases and Pregnancy Complications (group results)

C14. Cardiovascular Diseases (group results)

C15. Hemic and Lymphatic Diseases (group results)

C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities (group results)

C17. Skin and Connective Tissue Diseases (group results)

C18. Nutritional and Metabolic Diseases (group results)

C19. Endocrine System Diseases (group results)

C20. Immune System Diseases (group results)

C21. Disorders of Environmental Origin

C22. Animal Diseases (group results)

C23. Pathological Conditions, Signs and Symptoms (group results)

C24. Occupational Diseases (group results)

C25. Chemically-Induced Disorders (group results)

C26. Wounds and Injuries (group results)

D01. Inorganic Chemicals (group results)

D02. Organic Chemicals (group results)

D03. Heterocyclic Compounds (group results)

D04. Polycyclic Compounds (group results)

D05. Macromolecular Substances

D06. Hormones, Hormone Substitutes, and Hormone Antagonists

D08. Enzymes and Coenzymes

D09. Carbohydrates (group results)

D10. Lipids (group results)

D12. Amino Acids, Peptides, and Proteins (group results)

D13. Nucleic Acids, Nucleotides, and Nucleosides (group results)

D20. Complex Mixtures

D23. Biological Factors (group results)

D25. Biomedical and Dental Materials

D26. Pharmaceutical Preparations

D27. Chemical Actions and Uses: all > Pharmacologic Actions [MESH:D020228]

E. Analytical, Diagnostic and Therapeutic Techniques and Equipment (group results)

F. Psychiatry and Psychology (group results)

G. Phenomena and Processes (group results)

I. Anthropology, Education, Sociology and Social Phenomena

J. Technology, Industry, Agriculture

N. Health Care

Recently Viewed Items
 
These terms define your current search. Click the
×
to remove a term.

1. Human Genes: Basic helix-loop-helix [HGNC:BHLH] > hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [HGNC:HIF1A]
×
D27. Chemical Actions and Uses: Pharmacologic Actions [MESH:D020228]
×

29 items, grouped by D27. Chemical Actions and Uses (view ungrouped items)

Molecular Mechanisms of Pharmacological Action [MESH:D045504] (19)   
MESH:C001277
 geldanamycin
C001277
 
  
  
  
MESH:C005435
 phenylmethylpyrazolone
C005435
 
  
  
  
MESH:C009687
 wortmannin
C009687
 
  
  
  
MESH:C010953
 exochelins
C010953
 
  
  
  
MESH:C025205
 1,10-phenanthroline
C025205
 
  
  
  
MESH:C044387
 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine
C044387
 
  
  
  
MESH:C045651
 epigallocatechin gallate
C045651
 
  
  
  
MESH:C067713
 lactacystin
C067713
 
  
  
  
MESH:C072105
 KN 93
C072105
 
  
  
  
MESH:C072553
 benzyloxycarbonylleucyl-leucyl-leucine aldehyde
C072553
 
  
  
  
MESH:C085911
 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
C085911
 
  
  
  
MESH:C090937
 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
C090937
 
  
  
  
MESH:C090942
 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole
C090942
 
  
  
  
MESH:C093642
 SB 203580
C093642
 
  
  
  
MESH:C093973
 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
C093973
 
  
  
  
MESH:C110904
 capecitabine
C110904
 
  
  
  
MESH:C111237
 vorinostat
C111237
 
  
  
  
MESH:C113580
 U 0126
C113580
 
  
  
  
MESH:D020030
 Nitric Oxide Donors
D020030
 
  
  
  

Physiological Effects of Drugs [MESH:D045505] (11)   
MESH:C007768
 formononetin
C007768
 
  
  
  
MESH:C009687
 wortmannin
C009687
 
  
  
  
MESH:C015423
 peoniflorin
C015423
 
  
  
  
MESH:C025205
 1,10-phenanthroline
C025205
 
  
  
  
MESH:C030419
 andrographolide
C030419
 
  
  
  
MESH:C044387
 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine
C044387
 
  
  
  
MESH:C045651
 epigallocatechin gallate
C045651
 
  
  
  
MESH:C057693
 troglitazone
C057693
 
  
  
  
MESH:C089730
 rosiglitazone
C089730
 
  
  
  
MESH:C093642
 SB 203580
C093642
 
  
  
  
MESH:C097240
 15-deoxy-delta(12,14)-prostaglandin J2
C097240
 
  
  
  

Therapeutic Uses [MESH:D045506] (16)   
MESH:C001277
 geldanamycin
C001277
 
  
  
  
MESH:C009687
 wortmannin
C009687
 
  
  
  
MESH:C010327
 salinomycin
C010327
 
  
  
  
MESH:C011585
 ciclopirox
C011585
 
  
  
  
MESH:C015423
 peoniflorin
C015423
 
  
  
  
MESH:C030419
 andrographolide
C030419
 
  
  
  
MESH:C045651
 epigallocatechin gallate
C045651
 
  
  
  
MESH:C067713
 lactacystin
C067713
 
  
  
  
MESH:C072553
 benzyloxycarbonylleucyl-leucyl-leucine aldehyde
C072553
 
  
  
  
MESH:C090937
 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
C090937
 
  
  
  
MESH:C093642
 SB 203580
C093642
 
  
  
  
MESH:C101670
 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate
C101670
 
  
  
  
MESH:C110904
 capecitabine
C110904
 
  
  
  
MESH:C111237
 vorinostat
C111237
 
  
  
  
MESH:C400082
 bortezomib
C400082
 
  
  
  
MESH:D020030
 Nitric Oxide Donors
D020030